Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1

Conditions

Signs and Symptoms 1Sexuality 1Sexual Dysfunction, Physiological 1Hematologic Neoplasms 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Interventional × Sexual Health × Clear all
NCT05222282 2023-09-28

Sexual Health in Patients With Hematologic Malignancies

Rigshospitalet, Denmark

Phase NA Unknown
110 enrolled
OtherOther hematologic neoplasm

Sexual Dysfunction, Physiological, Signs and Symptoms, Hematologic Neoplasms, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡